Book Review

References

• Alta J. F., Bennet D. R., Anderson R. E. Cranial CT appearance of acute multiple sclerosis. Neurology 1978; 28: 251–255
   PubMedGoogle Scholar
• Bamford C. R., Sibley W. A., Thies C. Seasonal variations of multiple sclerosis exacerbations in Arizona. Neurology 1983; 33: 697–701
   PubMed Web of Science ®Google Scholar
• Beebe G. W., Kurtzke J. F., Karland L. T., Auth T. L., Nagler B. Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the army experience in World War II. Neurology 1967; 17: 1–17
   PubMed Web of Science ®Google Scholar
• Berg O., Hanley J. Narcolepsy in two cases of multiple sclerosis. Acta Neurologica Scandinavica 1963; 39: 252–257
   PubMed Web of Science ®Google Scholar
• Caine E. D., Bamford H. A., Schiffer R. B. A controlled neuropsychological comparison of Huntington's disease and multiple sclerosis. Archives of Neurology 1986; 43: 249–254
   PubMed Web of Science ®Google Scholar
• Carnegie P. R. Relationship of methylanginine to the main encephalitogenic determinant and some speculative implications for multiple sclerosis. Multiple sclerosis progress in research, E. J. Field, T. M. Bell, P. R. Carnegie. North Holland Publishing, Amsterdam 1972; 63–69
   Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Crellin R. F., Bottiglieri T., Reynolds E. H. Multiple sclerosis and macrocytosis. Lancet 1989; 1: 1157
   Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates C. M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Ekbom K. Familial multiple sclerosis associated with narcolepsy. Archives of Neurology 1966; 15: 337–344
   PubMedGoogle Scholar
• Flax J. W., Gray J., Herbert J. Effect of fluoxetine on patients with multiple sclerosis. American Journal of Psychiatry 1991; 148: 1603
   PubMed Web of Science ®Google Scholar
• Franklin G. M., Nelson L. M., Filley C. M., Heaton R. K. Cognitive loss in multiple sclerosis. Case reports and review of the literature. Archives of Neurology 1989; 46: 162–167
   PubMed Web of Science ®Google Scholar
• Harrer G., Fischbach R. Uber die wirkung bestimmter aminosauren auf das ergebniss des unberwar‐mungstests bein multiple sclerose kranken. Journal of Neural Transmission 1973; 34: 205–214
   PubMed Web of Science ®Google Scholar
• Hyyppa M. T., Jolma T., Riekkinen P., Rinne U. K. Effects of L‐tryptophan on central indoleamine metabolism and short‐lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission 1975; 37: 297–304
   PubMed Web of Science ®Google Scholar
• Jacobs B. L., Fornal C. A. 5‐HT and motor control: a hypothesis. Trends in Neurosciences 1993; 16: 346–352
   PubMed Web of Science ®Google Scholar
• Joffe R. T., Lippert G. P., Gray T. A. Mood disorder and multiple sclerosis. Archives of Neurology 1987; 44: 376–378
   PubMed Web of Science ®Google Scholar
• Johansson B., Ross B. E. 5‐hydroxyindoleacetic acid and homovanillic acid in CSF of patients with neurological disease. European Neurology 1977; 11: 37–45
   Web of Science ®Google Scholar
• Kellner C. H., Davenport Y., Post R. M., Ross R. J. Rapidly cycling bipolar disorder and multiple sclerosis. American Journal of Psychiatry 1984; 141: 112–113
   PubMed Web of Science ®Google Scholar
• Kirk A., Kertesz A. On drawing impairment in Alzheimer's disease. Archives of Neurology 1991; 48: 73–77
   PubMed Web of Science ®Google Scholar
• Kisser W., Harrer G. Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift 1974; 86: 80–82
   PubMed Web of Science ®Google Scholar
• Koopmans R. A., Li D. K. B., Oger J. J. F., Mayo J., Paty D. W. The lesion of multiple sclerosis imaging of acute and chronic stages. Neurology 1989; 39: 959–963
   PubMed Web of Science ®Google Scholar
• Kurtzke J. F. A reassessment of the distribution of multiple sclerosis. Part one, part two. Acta Neurologica Scandinavica 1975; 51: 110–136
   PubMed Web of Science ®Google Scholar
• Kurtzke J. F. The geographic distribution of multiple sclerosis: an update with special reference to Europe and the Mediterranean region. Acta Neurologica Scandinavica 1980; 62: 62–80
   Web of Science ®Google Scholar
• Lennon V. A., Carnegie P. R. Immunopharmacological disease: a break in tolerance to receptor sites. Lancet 1971; 2: 630–633
   Google Scholar
• Li D. K. B., Mayo J., Fache S., Robertson W., Lastrukoff L. F., Oger J., Paty D. W. Lack of correlation between clinical manifestations and lesions of MS as seen by NMR. Neurology 1984; 34: 136, (suppl)
   PubMed Web of Science ®Google Scholar
• Limburg C. C. The geographic distribution of multiple sclerosis and its estimated prevalence in the U.S. Proceedings of the Association for Research in Nervous and Mental Disease 1950; 28: 15–24
   PubMedGoogle Scholar
• Lynch S. G., Rose J. W., Smoker W., Petajan J. H. MRI in familial multiple sclerosis. Neurology 1990; 40: 900–903
   PubMed Web of Science ®Google Scholar
• MackKay R. P., Hirano A. Forms of benign multiple sclerosis: report of two clinically silent cases discovered at autopsy. Archives of Neurology 1967; 17: 588–600
   PubMedGoogle Scholar
• Markianos M., Sfagos C. Altered serotonin uptake kinetics in multiple sclerosis. Journal of Neurology 1988; 235: 236–237
   PubMed Web of Science ®Google Scholar
• Martin M. C., Hoffman P. G. The endocrinology of pregnancy in F. Basic and clinical endocrinology2nd edition, S. Grenspan, P. H. Forsham. Lange Medical, Los Altos, CA 1986; 476–488
   Google Scholar
• McDonald W. I. Pathophysiology of conduction in central nerve fibres. Visual evoked potentials in man: new developments, J. Desmedt. Claredon Press, Oxford 1977; 423–437
   Google Scholar
• McDonald W. I., Barnes D. Lesson from magnetic resonance imaging in multiple sclerosis. Trends in Neuroscience 1989; 12: 376–379
   PubMed Web of Science ®Google Scholar
• Millar J. H. D., Allison R. S., Cheeseman E. A., Merrett J. D. Pregnancy as a factor influencing relapse in disseminated sclerosis. Brain 1959; 82: 417–426
   PubMed Web of Science ®Google Scholar
• Najim Al‐Din A. S., Khojali M., Habbosh H., Farah S., Idris A. R., Al‐Muhtasib F. Macrocytosis in multiple sclerosis: a study in 82 de novo Arab patients. Journal of Neurology, Neurosurgery and Psychiatry 1991; 54: 415–416
   PubMed Web of Science ®Google Scholar
• O'Reilly M. A. R., O'Reilly P. M. R. Temporal influences on relapses of multiple sclerosis. European Neurology 1991; 31: 391–395
   PubMed Web of Science ®Google Scholar
• Ormerod I. E. C., du Boulay G. H., McDonald W. I. Imaging of multiple sclerosis. Multiple sclerosis, W. I. McDonald, D. H. Silberg. Butterworths, London 1986; 11–36
   Google Scholar
• Phadke J. G., Best P. V. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. Journal of Neurology, Neurosurgery mid Psychiatry 1983; 46: 414–420
   PubMed Web of Science ®Google Scholar
• Poirier G., Montplaisir J., Dumont M. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology 1987; 37: 693–695
   PubMed Web of Science ®Google Scholar
• Poser C. M. Multiple sclerosis observations and reflections‐a personal memoir. Journal of the Neurological Sciences 1992; 107: 127–140
   PubMed Web of Science ®Google Scholar
• Prineas J. W. The etiology and pathogenesis of multiple sclerosis. Multiple sclerosis and other demyelinating diseases, P. J. Vinken, G. W. Bruyn. North Holland, Amsterdam 1970; 107–160
   Google Scholar
• Rao S. M. Neuropsychology of multiple sclerosis: a critical review. Journal of Clinical and Experimental Neuropsychology 1986; 8: 503–542
   PubMed Web of Science ®Google Scholar
• Reynolds E. H., Linnell J. C. Vitamin B12 deficiency, demyelination, and multiple sclerosis. Lancet 1987; 2: 920
   PubMedGoogle Scholar
• Reynolds E. H., Linnell J. C., Faludy J. E. Multiple sclerosis associated with vitamin B12 deficiency. Archives of Neurology 1991; 48: 808–811
   PubMedGoogle Scholar
• Sandyk R. The pineal gland and multiple sclerosis. (Editorial). International Journal of Neuroscience 1992a; 63: 206–215
   Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992b; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. Demyelination as an epiphenomenon in multiple sclerosis. International Journal of Neuroscience 1993a; 72: 141–148
   PubMedGoogle Scholar
• Sandyk R. Multiple sclerosis the role of puberty and the pineal gland in its pathogenesis. International Journal of Neuroscience 1993b; 68: 209–225
   PubMedGoogle Scholar
• Sandyk R. Rapid normalization of visual evoked potentials by picotesla range magnetic fields in chronic progressive multiple sclerosis. International Journal of Neuroscience
   Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. The pineal gland in multiple sclerosis. International Journal of Neuroscience 1991; 61: 61–67
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal plasma melatonin and alpha‐melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. International Journal of Neuroscience 1992; 67: 173–186
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. International Journal of Neuroscience 1993a; 68: 227–240
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Multiple sclerosis: the role of the pineal gland in its timing of onset and risk of psychiatric illness. International Journal of Neuroscience 1993; 72: 95–106
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in suicidal patients with multiple sclerosis. International Journal of Neuroscience 1993; 71: 173–182
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience 1993a; 70: 97–105
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience 1993b; 68: 241–253
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience 1993; 70: 255–269
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. The co‐occurrence of multiple sclerosis and migraine headache: the serotoninergic link. International Journal of Neuroscience 1994; 76: 249–257
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Multiple sclerosis: Improvement of visuoperceptive functions by picotesla range magnetic fields. International Journal of Neuroscience 1994; 74: 177–189
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Improvement by picotesla magnetic fields of perceptual‐motor performance in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience
   Web of Science ®Google Scholar
• Schapira K., Poskanzer D. C., Newell D. J., Miller H. Marriage, pregnancy and multiple sclerosis. Brain 1966; 89: 419–428
   PubMed Web of Science ®Google Scholar
• Schiffer R. B., Wineman N. M., Weitkamp L. R. Association between bipolart affective disorder and multiple sclerosis. American Journal of Psychiatry 1986; 143: 94–95
   PubMed Web of Science ®Google Scholar
• Schrader H., Goltlibsen O. B., Slomedial G. M. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology 1980; 30: 105–108
   PubMed Web of Science ®Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Tabaddor K., Wolfson L. I., Sharpless N. S. Ventricular fluid homovanillic acid and 5‐hydroxyin‐doleacetic acid concentrations in patients with movement disorders. Neurology 1978; 28: 1249–1253
   PubMed Web of Science ®Google Scholar
• Taub R. G., Rucker C. W. The relationship of retrobulbar neuritis to multiple sclerosis. American Journal of Opthalmology 1954; 37: 494–497
   PubMed Web of Science ®Google Scholar
• Vuia O. The benign form of multiple sclerosis anatomoclinical aspects. Acta Neurologica Scandinavica 1977; 55: 289–293
   PubMed Web of Science ®Google Scholar
• Warren S., Warren K. G. Multiple sclerosis and associated diseases: A relationship to diabetes mellitus. Canadian Journal of Neurological Sciences 1981; 8: 35–39
   PubMed Web of Science ®Google Scholar
• Warren S. A., Warren K. G. Multiple sclerosis and diabetes mellitus: Further evidence fora relationship. Canadian Journal of Neurological Sciences 1982; 11: 415–419
   Google Scholar
• Wisniewski H. M., Keith A. B. Chronic relapsing experimental allergic encephalomyelitis. An experimental model of multiple sclerosis. Annals of Neurology 1977; 1: 144–148
   PubMed Web of Science ®Google Scholar
• Wurtman R. J., Axelrod J. The pineal gland. Scientific American 1965; 231: 50–60
   Web of Science ®Google Scholar
• Wuthrich R., Rieder H. P. The seasonal incidence of multiple sclerosis in Switzerland. European Neurology 1970; 3: 251–264
   Web of Science ®Google Scholar
• Young I. R., Hall A. S., Pallis C. A. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981; 2: 1063–1066
   PubMed Web of Science ®Google Scholar
• Younger D. S., Pedley T. A., Thorpy M. J. Multiple sclerosis and narcolepsy: possible similar genetic susceptibility. Neurology 1991; 41: 447–448
   PubMed Web of Science ®Google Scholar